Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON40099Active, not recruiting
Open-label, single-arm trial of carbamazepine, sponsored by University Medical Center Groningen. Primary endpoint: Shift of spontaneous otoacoustic emission frequencies related to carbamazepine use. Started Sep 2014; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON40099.